Group One Trading’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.4M | Sell |
85,000
-19,000
| -18% | -$3.28M | 0.03% | 644 |
|
|
2025
Q4 | $19M | Buy |
104,000
+6,000
| +6% | +$838K | 0.03% | 579 |
|
|
2025
Q3 | $11.9M | Buy |
98,000
+14,700
| +18% | +$1.66M | 0.02% | 794 |
|
|
2025
Q2 | $8.7M | Sell |
83,300
-6,400
| -7% | -$678K | 0.02% | 915 |
|
|
2025
Q1 | $10.5M | Sell |
89,700
-47,400
| -35% | -$5.4M | 0.03% | 604 |
|
|
2024
Q4 | $11.6M | Sell |
137,100
-600
| -0.4% | -$55.2K | 0.03% | 616 |
|
|
2024
Q3 | $12.4M | Sell |
137,700
-16,500
| -11% | -$1.44M | 0.04% | 496 |
|
|
2024
Q2 | $12.4M | Buy |
154,200
+74,200
| +93% | +$5.49M | 0.05% | 347 |
|
|
2024
Q1 | $6.38M | Sell |
80,000
-67,600
| -46% | -$5.67M | 0.02% | 676 |
|
|
2023
Q4 | $11.7M | Buy |
147,600
+53,300
| +57% | +$3.56M | 0.03% | 608 |
|
|
2023
Q3 | $6.59M | Sell |
94,300
-60,800
| -39% | -$4.55M | 0.02% | 759 |
|
|
2023
Q2 | $11.1M | Buy |
155,100
+76,800
| +98% | +$5.67M | 0.04% | 457 |
|
|
2023
Q1 | $4.83M | Sell |
78,300
-156,800
| -67% | -$10.3M | 0.02% | 855 |
|
|
2022
Q4 | $18.1M | Buy |
235,100
+93,200
| +66% | +$5.57M | 0.04% | 449 |
|
|
2022
Q3 | $6.33M | Sell |
141,900
-11,200
| -7% | -$560K | 0.01% | 996 |
|
|
2022
Q2 | $5.86M | Sell |
153,100
-261,800
| -63% | -$8.28M | 0.01% | 1178 |
|
|
2022
Q1 | $17.2M | Sell |
414,900
-527,100
| -56% | -$16.3M | 0.02% | 688 |
|
|
2021
Q4 | $35.6M | Buy |
942,000
+803,900
| +582% | +$29.6M | 0.03% | 414 |
|
|
2021
Q3 | $4.55M | Buy |
138,100
+110,300
| +397% | +$4.3M | ﹤0.01% | 1798 |
|
|
2021
Q2 | $1.88M | Buy |
27,800
+8,800
| +46% | +$528K | ﹤0.01% | 2721 |
|
|
2021
Q1 | $1.08M | Sell |
19,000
-154,500
| -89% | -$10.9M | ﹤0.01% | 3141 |
|
|
2020
Q4 | $14.1M | Buy |
173,500
+137,700
| +385% | +$10.3M | 0.02% | 603 |
|
|
2020
Q3 | $2.55M | Sell |
35,800
-27,700
| -44% | -$2.16M | 0.01% | 1408 |
|
|
2020
Q2 | $5.22M | Sell |
63,500
-96,200
| -60% | -$7.4M | 0.02% | 780 |
|
|
2020
Q1 | $9.39M | Sell |
159,700
-174,300
| -52% | -$14.2M | 0.08% | 281 |
|
|
2019
Q4 | $34.5M | Buy |
334,000
+147,800
| +79% | +$5.97M | 0.23% | 62 |
|
|
2019
Q3 | $3.77M | Buy |
186,200
+7,200
| +4% | +$185K | 0.03% | 758 |
|
|
2019
Q2 | $4.61M | Sell |
179,000
-190,900
| -52% | -$3.83M | 0.04% | 570 |
|
|
2019
Q1 | $5.26M | Buy |
369,900
+359,800
| +3,562% | +$3.34M | 0.06% | 401 |
|
|
2018
Q4 | $28K | Buy |
10,100
+5,600
| +124% | +$18.4K | ﹤0.01% | 3851 |
|
|
2018
Q3 | $16K | Sell |
4,500
-2,700
| -38% | -$8K | ﹤0.01% | 4457 |
|
|
2018
Q2 | $23K | Sell |
7,200
-8,400
| -54% | -$26K | ﹤0.01% | 4316 |
|
|
2018
Q1 | $38K | Buy |
+15,600
| New | +$46.7K | ﹤0.01% | 3777 |
|
Other funds holding AXSM
VPM
VCM
DTC
Group One Trading's AXSM Position: Q1 2026 in Review
Group One Trading reduced its Axsome Therapeutics (AXSM) stake by 99% in Q1 2026, selling an estimated $3.8M and leaving 214 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5517.
Group One Trading first reported a position in AXSM in Q4 2017 and has held it in 32 quarters since. The position peaked at $15.6M in Q4 2021. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.
- Group One Trading held 214 shares of Axsome Therapeutics worth $36.2K as of Q1 2026.
- Group One Trading sold 21,997 Axsome Therapeutics shares in Q1 2026, an estimated $3.8M.
- Axsome Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5517 holding.
- Group One Trading first reported a position in Axsome Therapeutics in Q4 2017 and has held it in 32 quarters since.
- Group One Trading's Axsome Therapeutics position peaked at $15.6M in Q4 2021.
- 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.